Research Paper Volume 13, Issue 9 pp 12849—12864
The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
Figure 2. Survival analysis of ZBTB7C in different tumors. OS and Cox regression analyses of (A, E) colon adenocarcinoma (COAD), (B, F) lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), (C, G) esophageal carcinoma (ESCA) and (D, H) mesothelioma (MESO). OS, overall survival.